EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Ovid Therapeutics Inc.
OVID

OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc. · NASDAQ
Market Closed
2.69
▲ ⁦+2.28%⁩ (+0.06)
Market Cap$502.1M
Beta0.23
52w Low52w High
1.123.11
Last Week
⁦-0.74%⁩
Last Month
⁦+2.28%⁩
Last 3 Months
⁦+12.55%⁩
Last Year
⁦+118.70%⁩
EL7 Factor Analysis
How we score this
Overall23
Poor — bottom quartile of the marketMomentum TrapF 3/9Better than 23% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
7
—17.8xBottom tier
▸
Growth
48
—7.1%Around median
▸
Quality
11
-39.9%▼4.5%Bottom tier
▸
Safety
94
—2.6xTop tier
▸
Capital Return
72
—2.12%Top tier
▸
Momentum
87
107.0%▲2.9%Top tier
▸
Sentiment
79
8▲3Top tier

Frequently Asked Questions

What is Ovid Therapeutics Inc. stock?▼

Ovid Therapeutics Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Ovid Therapeutics Inc.?▼

You can buy Ovid Therapeutics Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Ovid Therapeutics Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Ovid Therapeutics Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Ovid Therapeutics Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$2.69
Analyst target · 6 analysts
$6.50
—
Range ⁦$5.00–$8.00⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 6 analysts setting price target
$6.50
⁦+141.6%⁩
Current Price $2.69·Median $6.50
Low
$5.00
High
$8.00
Current price
$2.69
Average target
$6.50
Street summary

Higher Consensus Price Target Amid Continued Positive Ratings

Bullish tilt

The consensus price target rose from 5.5 to 6.5 over the last 30 days, an increase of 18.18%, and from 6 to 6.5 over the last 7 days and 1 day, an increase of 8.33%. The number of analysts remained at 6, while the current range is between 5 and 8, reflecting continued divergence despite the improvement in consensus. At the current price of 2.69, the consensus remains higher, without implying any guarantee that the targets will be achieved.

As of 2026-09-11
Revisions momentum · 30d
⁦+18.2%⁩
Average rating
★ 4.00
Buy
Analyst coverage
10
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
112%
Wide
Analyst ratings over time10 analysts rating
10
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.00 → 4.00
Recent analyst moves
  • = Reiterate2026-09-11
    UBS
    Buy
  • = Reiterate2026-09-11
    H.C. Wainwright
    Buy
  • = Reiterate2026-09-03
    Roth MKM
    Buy
Premium content
Financial Analysis
|